← Braidwell portfolio
13F-HR filing
VALIDATEDHoldings period 2024-03-31 · Filed 2024-05-15 · Accession 0001920938-24-000004
Open official SEC source ↗| # | Issuer | Class / CUSIP | Kind | Shares | Value |
|---|---|---|---|---|---|
| 1 | 4D MOLECULAR THERAPEUTICS IN | COM · 35104E100 | LONG | 1,052,485 | $33.5 million |
| 2 | ADAPTIVE BIOTECHNOLOGIES COR | COM · 00650F109 | LONG | 1,357,490 | $4.4 million |
| 3 | ALECTOR INC | COM · 014442107 | LONG | 2,380,704 | $14.3 million |
| 4 | ALIGN TECHNOLOGY INC | COM · 016255101 | LONG | 169,252 | $55.5 million |
| 5 | ALPHATEC HLDGS INC | NOTE 0.750% 8/0 · 02081GAB8 | LONG | 32,434,000 | $33.9 million |
| 6 | APOGEE THERAPEUTICS INC | COM · 03770N101 | LONG | 1,842,515 | $122.4 million |
| 7 | ARCUTIS BIOTHERAPEUTICS INC | COM · 03969K108 | LONG | 1,300,000 | $12.9 million |
| 8 | ARGENX SE | SPONSORED ADR · 04016X101 | LONG | 219,824 | $86.5 million |
| 9 | AVADEL PHARMACEUTICALS PLC | SPONSORED ADR · 05337M104 | LONG | 2,668,549 | $45.1 million |
| 10 | BIOCRYST PHARMACEUTICALS INC | COM · 09058V103 | LONG | 3,379,577 | $17.2 million |
| 11 | BIOMARIN PHARMACEUTICAL INC | COM · 09061G101 | LONG | 218,896 | $19.1 million |
| 12 | BRIDGEBIO PHARMA INC | COM · 10806X102 | LONG | 344,827 | $10.7 million |
| 13 | BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 · 10806XAD4 | LONG | 67,294,000 | $55.1 million |
| 14 | BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 · 10806XAB8 | LONG | 135,838,000 | $146.2 million |
| 15 | CG ONCOLOGY INC | COM · 156944100 | LONG | 1,130,235 | $49.6 million |
| 16 | CULLINAN THERAPEUTICS INC | COM · 230031106 | LONG | 1,240,865 | $21.1 million |
| 17 | CUTERA INC | NOTE 4.000% 6/0 · 232109AG3 | LONG | 29,000,000 | $6.4 million |
| 18 | CUTERA INC | NOTE 2.250% 6/0 · 232109AD0 | LONG | 25,240,000 | $5.7 million |
| 19 | DAY ONE BIOPHARMACEUTICALS I | COM · 23954D109 | LONG | 2,173,704 | $35.9 million |
| 20 | DBV TECHNOLOGIES S A | SPONSORED ADR · 23306J101 | LONG | 7,843,285 | $5.9 million |
| 21 | DECIPHERA PHARMACEUTICALS IN | COM · 24344T101 | LONG | 609,643 | $9.6 million |
| 22 | DEXCOM INC | NOTE 0.250%11/1 · 252131AK3 | LONG | 65,000,000 | $71.6 million |
| 23 | ELEVATION ONCOLOGY INC | COM · 28623U101 | LONG | 2,377,647 | $12.2 million |
| 24 | EXACT SCIENCES CORP | NOTE 0.375% 3/0 · 30063PAC9 | LONG | 144,000,000 | $133.1 million |
| 25 | GLAUKOS CORP | COM · 377322102 | LONG | 450,676 | $42.5 million |
| 26 | GUARDANT HEALTH INC | COM · 40131M109 | LONG | 2,476,804 | $51.1 million |
| 27 | GUARDANT HEALTH INC | NOTE11/1 · 40131MAB5 | LONG | 268,252,000 | $183.6 million |
| 28 | HAEMONETICS CORP MASS | NOTE3/0 · 405024AB6 | LONG | 21,500,000 | $19.8 million |
| 29 | HARROW INC | COM · 415858109 | LONG | 125,967 | $1.7 million |
| 30 | INSMED INC | NOTE 1.750% 1/1 · 457669AA7 | LONG | 64,887,000 | $69.4 million |
| 31 | INSPIRE MED SYS INC | COM · 457730109 | LONG | 101,492 | $21.8 million |
| 32 | INSULET CORP | NOTE 0.375% 9/0 · 45784PAK7 | LONG | 66,000,000 | $68.9 million |
| 33 | INTUITIVE SURGICAL INC | COM NEW · 46120E602 | LONG | 100,500 | $40.1 million |
| 34 | IOVANCE BIOTHERAPEUTICS INC | COM · 462260100 | LONG | 660,022 | $9.8 million |
| 35 | IRHYTHM HOLDINGS INC | COM · 450056106 | LONG | 483,257 | $56.1 million |
| 36 | IRONWOOD PHARMACEUTICALS INC | COM CL A · 46333X108 | LONG | 3,489,843 | $30.4 million |
| 37 | IRONWOOD PHARMACEUTICALS INC | NOTE 0.750% 6/1 · 46333XAF5 | LONG | 20,000,000 | $19.9 million |
| 38 | IRONWOOD PHARMACEUTICALS INC | NOTE 1.500% 6/1 · 46333XAH1 | LONG | 52,740,000 | $53.7 million |
| 39 | ITEOS THERAPEUTICS INC | COM · 46565G104 | LONG | 1,162,374 | $15.9 million |
| 40 | KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 · 48576UAA4 | LONG | 65,976,000 | $35.8 million |
| 41 | KEROS THERAPEUTICS INC | COM · 492327101 | LONG | 737,379 | $48.8 million |
| 42 | KINIKSA PHARMACEUTICALS LTD | COM CL A · G5269C101 | LONG | 1,392,716 | $27.5 million |
| 43 | KRYSTAL BIOTECH INC | COM · 501147102 | LONG | 177,089 | $31.5 million |
| 44 | LEGEND BIOTECH CORP | SPONSORED ADS · 52490G102 | LONG | 1,243,795 | $69.8 million |
| 45 | LEXEO THERAPEUTICS INC | COM · 52886X107 | LONG | 1,322,277 | $20.7 million |
| 46 | MARAVAI LIFESCIENCES HLDGS I | COM CL A · 56600D107 | LONG | 7,221,960 | $62.6 million |
| 47 | MINERALYS THERAPEUTICS INC | COM · 603170101 | LONG | 1,147,154 | $14.8 million |
| 48 | NEOGENOMICS INC | NOTE 0.250% 1/1 · 64049MAB6 | LONG | 103,580,000 | $82.6 million |
| 49 | NEUROCRINE BIOSCIENCES INC | COM · 64125C109 | LONG | 730,209 | $100.7 million |
| 50 | NEVRO CORP | COM · 64157F103 | LONG | 1,776,368 | $25.7 million |
| 51 | NOVOCURE LTD | NOTE11/0 · 67011XAB9 | LONG | 135,834,000 | $124.6 million |
| 52 | NUVASIVE INC | NOTE 0.375% 3/1 · 670704AJ4 | LONG | 114,206,000 | $109.0 million |
| 53 | OLEMA PHARMACEUTICALS INC | COM · 68062P106 | LONG | 704,344 | $8.0 million |
| 54 | ORTHOPEDIATRICS CORP | COM · 68752L100 | LONG | 1,107,770 | $32.3 million |
| 55 | OUTSET MED INC | COM · 690145107 | LONG | 2,400,427 | $5.3 million |
| 56 | PARAGON 28 INC | COM · 69913P105 | LONG | 3,365,609 | $41.6 million |
| 57 | PENUMBRA INC | COM · 70975L107 | LONG | 295,892 | $66.0 million |
| 58 | PULMONX CORP | COM · 745848101 | LONG | 752,541 | $7.0 million |
| 59 | RELAY THERAPEUTICS INC | COM · 75943R102 | LONG | 3,743,999 | $31.1 million |
| 60 | REPLIGEN CORP | COM · 759916109 | LONG | 142,836 | $26.3 million |
| 61 | SAREPTA THERAPEUTICS INC | NOTE 1.250% 9/1 · 803607AD2 | LONG | 50,666,000 | $59.3 million |
| 62 | SPYRE THERAPEUTICS INC | COM NEW · 00773J202 | LONG | 515,000 | $19.5 million |
| 63 | STRUCTURE THERAPEUTICS INC | SPONSORED ADS · 86366E106 | LONG | 435,823 | $18.7 million |
| 64 | THERMO FISHER SCIENTIFIC INC | COM · 883556102 | LONG | 47,149 | $27.4 million |
| 65 | TOURMALINE BIO INC | COM · 89157D105 | LONG | 906,820 | $20.8 million |
| 66 | TRANSMEDICS GROUP INC | COM · 89377M109 | LONG | 614,531 | $45.4 million |
| 67 | TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 · 761299AB2 | LONG | 56,031,000 | $49.6 million |
| 68 | VAXCYTE INC | COM · 92243G108 | LONG | 1,212,703 | $82.8 million |
| 69 | VIKING THERAPEUTICS INC | COM · 92686J106 | LONG | 713,100 | $58.5 million |
| 70 | XENON PHARMACEUTICALS INC | COM · 98420N105 | LONG | 1,308,011 | $56.3 million |